Clinical manifestations and outcome of skin infections caused by the community-acquired methicillin-resistant Staphylococcus aureus clone ST80-IV.

@article{Giudice2011ClinicalMA,
  title={Clinical manifestations and outcome of skin infections caused by the community-acquired methicillin-resistant Staphylococcus aureus clone ST80-IV.},
  author={Pascal del Giudice and Michelle Bes and Thomas Hubiche and Laurent Roudi{\`e}re and Vanessa Blanc and G{\'e}rard Lina and François Vandenesch and J. Etienne},
  journal={Journal of the European Academy of Dermatology and Venereology : JEADV},
  year={2011},
  volume={25 2},
  pages={164-9}
}
BACKGROUND Several Panton-Valentin leukocidin-positive clones of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) are spreading worldwide. The European clone ST80-IV is the main CA-MRSA clone in Europe. There is no reported study of the specific clinical manifestations and outcome of skin infections caused by the clone ST80-IV, using strict definitions of skin diseases. METHODS Single-centre observational prospective cohort of S. aureus skin infections caused by the… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 20 references

High rates of community-acquired, Panton-Valentine leukocidin (PVL)- positive methicillin-resistant S. aureus (MRSA) infections in adult outpatients in Greece.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin • 2009

Distribution of the exfoliative toxin D gene in clinical Staphylococcus aureus isolates in France.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases • 2006

Similar Papers

Loading similar papers…